Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects

被引:0
|
作者
Reza Elahi
Amir Hossein Heidary
Kaveh Hadiloo
Abdolreza Esmaeilzadeh
机构
[1] Zanjan University of Medical Sciences,School of Medicine
[2] Zanjan University of Medical Sciences,Department of Immunology
[3] Zanjan University of Medical Sciences,Cancer Gene Therapy Research Center (CGRC)
[4] Zanjan University of Medical Sciences,undefined
来源
关键词
Chimeric antigen receptor; Natural killer cell; Immunotherapy; Challenges; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2081 / 2106
页数:25
相关论文
共 50 条
  • [31] The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
    Yao, Pin
    Liu, Ya-Guang
    Huang, Gang
    Hao, Liangchun
    Wang, Runan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [32] A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    Zhang, Erhao
    Xu, Hanmei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 11
  • [33] A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    Erhao Zhang
    Hanmei Xu
    Journal of Hematology & Oncology, 10
  • [34] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Han, Ethan Q.
    Li, Xiu-ling
    Wang, Chun-rong
    Li, Tian-fang
    Han, Shuang-yin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [35] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Ethan Q Han
    Xiu-ling Li
    Chun-rong Wang
    Tian-fang Li
    Shuang-yin Han
    Journal of Hematology & Oncology, 6
  • [36] Application of chimeric antigen receptor-engineered T cells in ovarian cancer therapy
    Zhang, Minghui
    Zhang, Bin
    Shi, Huirong
    IMMUNOTHERAPY, 2017, 9 (10) : 851 - 861
  • [37] Targeting cardiac fibrosis with Chimeric Antigen Receptor-Engineered Cells
    Zhang, Qinghang
    Dai, Jinjie
    Liu, Tianbao
    Rao, Wutian
    Li, Dan
    Gu, Zhengying
    Huang, Lin
    Wang, Jiayi
    Hou, Xumin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, : 2103 - 2116
  • [38] Computational model of chimeric antigen receptor-engineered T cells
    Rohrs, Jennifer
    Wang, Pin
    Finley, Stacey D.
    CANCER RESEARCH, 2015, 75 (22)
  • [39] Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
    Zu, Yingling
    Ren, Quan
    Zhang, Jishuai
    Su, Hongchang
    Lu, Qiumei
    Song, Yongping
    Zhou, Jian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [40] Targeting hematological malignancies and solid tumors with switchable chimeric antigen receptor-engineered iPSC-derived natural killer cells
    Li, Xiao-Hua
    Goldenson, Benjamin
    Thangaraj, Jaya Lakshmi
    Gynn, Matthew
    Gumber, Diana
    Do, Myan
    Willert, Karl
    Kaufman, Dan S.
    CANCER RESEARCH, 2022, 82 (12)